0001055726-24-000006.txt : 20240228
0001055726-24-000006.hdr.sgml : 20240228
20240228171029
ACCESSION NUMBER: 0001055726-24-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240226
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weiner David B.
CENTRAL INDEX KEY: 0001669080
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 24696773
MAIL ADDRESS:
STREET 1: 717 BEACOM LANE
CITY: MERION STATION
STATE: PA
ZIP: 19066-1603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wk-form4_1709158215.xml
FORM 4
X0508
4
2024-02-26
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001669080
Weiner David B.
660 W. GERMANTOWN PIKE
SUITE 110
PLYMOUTH MEETING
PA
19462
1
0
0
0
0
Common Stock
2024-02-26
4
M
0
972
A
78399
D
Common Stock
2024-02-26
4
M
0
972
A
79371
D
Common Stock
2024-02-26
4
M
0
972
A
80343
D
Restricted Stock Unit
2024-02-26
4
M
0
972
0
D
Common Stock
972
0
D
Restricted Stock Unit
2024-02-26
4
M
0
972
0
D
Common Stock
972
972
D
Restricted Stock Unit
2024-02-26
4
M
0
972
0
D
Common Stock
972
1944
D
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.
Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
/s/ David B. Weiner
2024-02-28